Ravasio, R., S. Antonelli, V. Rogai, W. Fakhouri, J. P. Capron, and S. Losi. “Mean Cost Per Number Needed to Treat of Baricitinib Versus Adalimumab in the Treatment of Rheumatoid Arthritis in Italy”. Global and Regional Health Technology Assessment, vol. 5, no. 1, July 2018, doi:10.33393/grhta.2018.435.